Skip to main content

Mineralys Therapeutics, Inc.

MLYS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001933414

In the last 90 days, Mineralys Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 225 institutions reported holding it in 13F filings for Q2 2026, worth $2.69B in total; no superinvestor holds it.

Holders of 5% or more of MLYS

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Mineralys Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of MLYS
HolderLatest formStakeChangeFirst filedLatest filingFiling
Catalys Pacific Fund, LP13G/A10.10%8.00M shares−3.40 ppfrom 13.50%Feb 13, 20244 filingsFeb 13, 2026SEC
Ra Capital Management, L.P.13D/A9.90%7.80M shares0.00 ppfrom 9.90%Feb 24, 20234 filingsSep 8, 2025SEC
Samsara BioCapital, L.P.13D/A8.20%6.35M shares−0.90 ppfrom 9.10%Feb 24, 20234 filingsSep 8, 2025SEC
BlackRock, Inc.13G5.20%4.11M sharesNewJan 21, 20261 filingJan 21, 2026SEC
FMR LLC13G/A5.10%4.46M shares−1.20 ppfrom 6.30%Feb 5, 20262 filingsAug 6, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

23 Schedule 13D and 13G filings on Mineralys Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on MLYS
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 6, 202610:33 AM ETFMR LLCand 1 other13G/A5.10%4.46M shares−1.20 ppfrom 6.30%Jun 30, 2026SEC
Feb 13, 20264:30 PM ETCatalys Pacific Fund, LPand 3 others13G/A10.10%8.00M shares−3.40 ppfrom 13.50%Dec 31, 2025SEC
Feb 5, 20261:31 PM ETFMR LLCand 1 other13G6.30%5.02M sharesNewDec 31, 2025SEC
Jan 21, 202612:30 PM ETBlackRock, Inc.13G5.20%4.11M sharesNewDec 31, 2025SEC
Sep 8, 20258:05 PM ETSamsara BioCapital, L.P.and 4 others13D/A8.20%6.35M shares−0.90 ppfrom 9.10%Sep 4, 2025SEC
Sep 8, 20256:00 PM ETRa Capital Management, L.P.and 3 others13D/A9.90%7.80M shares0.00 ppfrom 9.90%Sep 4, 2025SEC
Aug 14, 20254:13 PM ETAndera Partnersand 3 others13G/A4.20%2.77M shares–Below 5%Jun 30, 2025SEC
Aug 14, 20254:05 PM ETCatalys Pacific Fund, LPand 3 others13G/A13.50%8.98M shares–Jun 30, 2025SEC
Mar 17, 20259:06 PM ETSamsara BioCapital, L.P.and 2 others13D/A9.10%5.74M shares–Mar 13, 2025SEC
Mar 17, 20257:58 PM ETRa Capital Management, L.P.and 3 others13D/A9.90%6.29M shares–Mar 13, 2025SEC
Feb 14, 20256:03 AM ETAdams Street Partners LLCand 7 others13G/A2.30%1.13M shares–Below 5%Dec 31, 2024SEC
Nov 13, 2024TCG Crossover GP II, LLC13G/AOld format–––SEC
Nov 13, 2024Catalys Pacific Fund, LP13G/AOld format–––SEC
Nov 13, 2024HBM Healthcare Investments (Cayman) Ltd.13G/AOld format–––SEC
Feb 15, 2024TCG Crossover GP II, LLC13GOld format–New–SEC
Feb 14, 2024Adams Street Partners LLC13GOld format–New–SEC
Feb 13, 2024Catalys Pacific Fund, LP13GOld format–New–SEC
Feb 13, 2024HBM Healthcare Investments (Cayman) Ltd.13GOld format–New–SEC
Feb 12, 2024Ra Capital Management, L.P.13D/AOld format–––SEC
Feb 12, 2024Samsara BioCapital, L.P.13D/AOld format–––SEC
Feb 24, 2023Andera Partners13GOld format–New–SEC
Feb 24, 2023Samsara BioCapital, L.P.13DOld format–New–SEC
Feb 24, 2023Ra Capital Management, L.P.13DOld format–New–SEC

Form 144: proposed insider sales

94 notices from officers, directors and other affiliates planning to sell Mineralys Therapeutics, Inc. shares, newest first.

Form 144 notices for MLYS
Filed (ET)SellerShares to sellMarket valuePlanned saleBrokerFiling
Oct 13, 20264:11 PM ETRodman David MalcomOfficer3.54K$78.1KOct 13, 202610b5-1Merrill LynchSEC
Sep 30, 20264:07 PM ETCongleton JonOfficer · Director75.0K$1.91MSep 30, 202610b5-1Merrill LynchSEC
Sep 22, 20264:09 PM ETCatalys Pacific Fund LPDirector104.3K$3.01MSep 22, 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesSEC
Sep 21, 20264:05 PM ETWarren EricOfficer7.44K$209.1KSep 21, 202610b5-1Merrill LynchSEC
Sep 17, 20264:06 PM ETRodman David MalcomOfficer417$11.7KSep 17, 202610b5-1Merrill LynchSEC
Sep 15, 20264:19 PM ETKarydas DaphneOfficer3.00K$85.7KSep 15, 202610b5-1Merrill LynchSEC
Sep 14, 20264:06 PM ETRodman David MalcomOfficer7.71K$216.9KSep 14, 202610b5-1Merrill LynchSEC
Sep 9, 20264:05 PM ETRodman David MalcomOfficer2.17K$67.0KSep 9, 202610b5-1Merrill LynchSEC
Aug 21, 20264:14 PM ETWarren EricOfficer7.44K$193.2KAug 21, 202610b5-1Merrill LynchSEC
Aug 17, 20264:38 PM ETRodman David MalcomOfficer417$10.6KAug 17, 202610b5-1Merrill LynchSEC
Aug 13, 20264:12 PM ETRodman David MalcomOfficer14.1K$372.2KAug 13, 202610b5-1Merrill LynchSEC
Aug 10, 20264:39 PM ETRodman David MalcomOfficer2.17K$58.8KAug 10, 202610b5-1Merrill LynchSEC
Jul 21, 20264:11 PM ETWarren EricOfficer7.44K$199.9KJul 21, 202610b5-1Merrill LynchSEC
Jul 17, 20264:03 PM ETRodman David MalcomOfficer416$11.0KJul 17, 202610b5-1Merrill LynchSEC
Jul 15, 20264:13 PM ETRodman David MalcomOfficer6.35K$169.0KJul 15, 202610b5-1Merrill LynchSEC
Jul 14, 202611:08 AM ETAmendedRodman David MalcomOfficer14.1K$387.7KJul 13, 202610b5-1Merrill LynchSEC
Jul 13, 20264:23 PM ETCongleton JonOfficer · Director10.7K$291.4KJul 13, 202610b5-1Merrill LynchSEC
Jul 9, 20264:10 PM ETRodman David MalcomOfficer2.17K$65.8KJul 9, 202610b5-1Merrill LynchSEC
Jun 30, 20264:20 PM ETCongleton JonOfficer75.0K$1.96MJun 30, 202610b5-1Merrill LynchSEC
Jun 29, 20269:05 AM ETWarren EricOfficer104.1K$2.70MJun 26, 202610b5-1Merrill LynchSEC
Jun 17, 20264:20 PM ETRodman David MalcomOfficer4.58K$114.6KJun 17, 202610b5-1Merrill LynchSEC
Jun 17, 20264:15 PM ETKarydas DaphneOfficer3.00K$75.0KJun 17, 202610b5-1Merrill LynchSEC
Jun 15, 20264:58 PM ETRodman David MalcomOfficer9.89K$235.5KJun 15, 202610b5-1Merrill LynchSEC
Jun 12, 20264:17 PM ETRodman David MalcomOfficer6.35K$151.9KJun 12, 202610b5-1Merrill LynchSEC
Jun 10, 20264:11 PM ETRodman David MalcomOfficer2.17K$54.3KJun 10, 202610b5-1Merrill LynchSEC

Showing the latest 25. See the MLYS notices from the last 12 months